Mandel-Brehm Josh reported CAMP

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001927058-25-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

Dec 11, 2025

Published

Dec 22, 2025

Ingested by INSIDER

Nov 5, 04:26 UTC

Last re-read

Nov 5, 04:26 UTC

Extracted facts

Filer

Mandel-Brehm Josh

Role

Director, Chief Executive Officer

Transaction

Grant or awardAs filed: “A”

Asset

Camp4 Therapeutics Corp — Stock Option (Right to Buy)

Ticker

CAMP

Shares

425.0K

Price per share

$0

Execution date (reported)

Dec 11, 2025

Owned after transaction

425.0K shares

Days from execution to publication

11

What this establishes

Mandel-Brehm Josh filed this Form 4 reporting a grant or award of CAMP on Dec 11, 2025. It became public on Dec 22, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, Chief Executive Officer

Mandel-Brehm Joshcik:0001927058

Issuer

Camp4 Therapeutics Corpcik:0001736730

Revision history · 0

No field has changed since this record was first ingested.